No. There have been years of serious quality problems at certain Indian manufacturers. Here's a case from 10 years ago:

During a visit to a facility of leading Indian drugmaker Ranbaxy Laboratories Ltd last year, U.S. inspectors found that a black fiber embedded in a tablet may have been a hair from an employee’s arm, according to documents seen by Reuters. ....

The Mohali plant, in the northern state of Punjab, had not been making U.S. exports since last November, when it voluntarily recalled its generic version of cholesterol-lowering drug Lipitor in the United States due to the potential presence of glass particles in certain batches.

Here's another case from last year:

A parliamentary committee in Gambia said on Tuesday that India-based drug maker Maiden Pharmaceuticals Ltd was responsible for the deaths of at least 70 children from acute kidney injury and called on the government to pursue legal action.

According to a WHO report, "labs contracted by it in Ghana and Switzerland found excess levels of ethyleneglycol and diethyleneglycol contaminants in the Maiden syrups."

https://www.reuters.com/world/africa/gambia-lawmakers-say-ma...

Note that the plant cited in the 2013 case was majority owned by a Japanese pharmaceutical company. They still couldn't get QC right.